Recombinant Human LAT1 Protein，His

LAT1 (L-type amino acid transporter 1) is a member of the SLC7 family of solute carriers, primarily responsible for the transport of large neutral amino acids across the plasma membrane. Its role is particularly crucial in various physiological processes, including neurotransmitter synthesis, cellular metabolism, and immune response. LAT1 is highly expressed in many tissues, especially in the brain and in rapidly proliferating cells, such as cancer cells, where it facilitates the uptake of essential amino acids that are vital for cell growth and survival. The dysregulation of LAT1 expression has been implicated in various pathological conditions, including tumors, neurodegenerative diseases, and metabolic disorders. Consequently, LAT1 has emerged as a potential therapeutic target for cancer treatment and metabolic regulation. Research efforts have focused on understanding its structural characteristics, substrate specificity, and transport mechanisms, as well as identifying inhibitors that could modulate its activity effectively. Recent advances in recombinant protein technology have enabled the production of functional LAT1, providing a valuable tool for detailed biochemical and pharmacological studies. Investigating LAT1 at the molecular level could pave the way for novel therapeutic approaches aimed at tackling diseases associated with its dysfunction. Overall, the study of LAT1 and its recombinant protein form holds significant promise for both basic research and clinical applications, highlighting its importance in the fields of biochemistry and medical science.